NASDAQ:EDAP - Nasdaq - US2683111072 - ADR - Currency: USD
NASDAQ:EDAP (5/7/2025, 4:30:02 PM)
2.3
+0.15 (+6.98%)
The current stock price of EDAP is 2.3 USD. In the past month the price increased by 57.39%. In the past year, price decreased by -67.75%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ABT | ABBOTT LABORATORIES | 28.02 | 232.31B | ||
ISRG | INTUITIVE SURGICAL INC | 70.18 | 192.17B | ||
BSX | BOSTON SCIENTIFIC CORP | 38.81 | 155.01B | ||
SYK | STRYKER CORP | 30.65 | 146.59B | ||
MDT | MEDTRONIC PLC | 15.57 | 106.66B | ||
BDX | BECTON DICKINSON AND CO | 11.86 | 47.99B | ||
EW | EDWARDS LIFESCIENCES CORP | 28.86 | 44.12B | ||
IDXX | IDEXX LABORATORIES INC | 42.69 | 39.43B | ||
RMD | RESMED INC | 26.95 | 35.88B | ||
DXCM | DEXCOM INC | 50.52 | 32.68B | ||
GEHC | GE HEALTHCARE TECHNOLOGY | 14.96 | 31.51B | ||
PHG | KONINKLIJKE PHILIPS NVR- NY | 15.51 | 22.46B |
EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. The company is headquartered in Vaulx-En-Velin, Auvergne-Rhone-Alpes and currently employs 310 full-time employees. The firm's activity is organized in two divisions: HIFU (High Intensity Focused Ultrasound) and ESWL (Extracorporeal ShockWave Lithotripsy) that invests in research and development, partnering with INSERM French public laboratory and international medical research institutions. The company specialises in HIFU technology, a non-invasive treatment of prostate conditions with a range of Robotic HIFU devices, Ablatherm Fusion and Focal One, ESWL and Stone Laser that offers a range of minimally invasive solutions covering the full scope of urinary tract stone indications. The company also operates worldwide via a network of corporate offices, subsidiaries and distribution partners
EDAP TMS SA -ADR
4, rue du Dauphine, PA La Poudrette Lamartine
Vaulx-en-Velin AUVERGNE-RHONE-ALPES 69120 FR
CEO: Marc Oczachowski
Employees: 310
Phone: 33472153150
The current stock price of EDAP is 2.3 USD. The price increased by 6.98% in the last trading session.
The exchange symbol of EDAP TMS SA -ADR is EDAP and it is listed on the Nasdaq exchange.
EDAP stock is listed on the Nasdaq exchange.
9 analysts have analysed EDAP and the average price target is 3.32 USD. This implies a price increase of 44.13% is expected in the next year compared to the current price of 2.3. Check the EDAP TMS SA -ADR stock analysts ratings, price target forecast and up-and down grades for more detailed information.
EDAP TMS SA -ADR (EDAP) has a market capitalization of 85.34M USD. This makes EDAP a Micro Cap stock.
EDAP TMS SA -ADR (EDAP) currently has 310 employees.
EDAP TMS SA -ADR (EDAP) has a support level at 2.15 and a resistance level at 2.66. Check the full technical report for a detailed analysis of EDAP support and resistance levels.
The Revenue of EDAP TMS SA -ADR (EDAP) is expected to decline by -0.06% in the next year. Check the estimates tab for more information on the EDAP EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
EDAP does not pay a dividend.
EDAP TMS SA -ADR (EDAP) will report earnings on 2025-05-14, before the market open.
EDAP TMS SA -ADR (EDAP) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.57).
The outstanding short interest for EDAP TMS SA -ADR (EDAP) is 0.25% of its float. Check the ownership tab for more information on the EDAP short interest.
ChartMill assigns a technical rating of 2 / 10 to EDAP. When comparing the yearly performance of all stocks, EDAP is a bad performer in the overall market: 88.73% of all stocks are doing better.
ChartMill assigns a fundamental rating of 2 / 10 to EDAP. While EDAP seems to be doing ok healthwise, there are quite some concerns on its profitability.
Over the last trailing twelve months EDAP reported a non-GAAP Earnings per Share(EPS) of -0.57. The EPS increased by 13.79% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -23.13% | ||
ROE | -37.2% | ||
Debt/Equity | 0.08 |
ChartMill assigns a Buy % Consensus number of 80% to EDAP. The Buy consensus is the average rating of analysts ratings from 9 analysts.
For the next year, analysts expect an EPS growth of -13.85% and a revenue growth -0.06% for EDAP